X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE LUPIN LTD TTK HEALTHCARE/
LUPIN LTD
 
P/E (TTM) x 30.4 16.3 186.9% View Chart
P/BV x 5.6 3.8 147.8% View Chart
Dividend Yield % 0.5 0.8 63.9%  

Financials

 TTK HEALTHCARE   LUPIN LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
LUPIN LTD
Mar-16
TTK HEALTHCARE/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs6632,127 31.2%   
Low Rs3991,294 30.8%   
Sales per share (Unadj.) Rs535.6304.1 176.1%  
Earnings per share (Unadj.) Rs15.950.4 31.6%  
Cash flow per share (Unadj.) Rs20.060.7 33.0%  
Dividends per share (Unadj.) Rs4.007.50 53.3%  
Dividend yield (eoy) %0.80.4 171.7%  
Book value per share (Unadj.) Rs137.6243.8 56.5%  
Shares outstanding (eoy) m7.77450.58 1.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.05.6 17.6%   
Avg P/E ratio x33.333.9 98.1%  
P/CF ratio (eoy) x26.528.2 94.1%  
Price / Book Value ratio x3.97.0 55.0%  
Dividend payout %25.114.9 168.6%   
Avg Mkt Cap Rs m4,127770,740 0.5%   
No. of employees `0001.716.4 10.4%   
Total wages/salary Rs m60721,077 2.9%   
Avg. sales/employee Rs Th2,436.78,379.6 29.1%   
Avg. wages/employee Rs Th355.21,289.0 27.6%   
Avg. net profit/employee Rs Th72.51,388.7 5.2%   
INCOME DATA
Net Sales Rs m4,162137,016 3.0%  
Other income Rs m611,877 3.3%   
Total revenues Rs m4,223138,893 3.0%   
Gross profit Rs m19737,535 0.5%  
Depreciation Rs m324,635 0.7%   
Interest Rs m30446 6.7%   
Profit before tax Rs m19734,330 0.6%   
Minority Interest Rs m0-88 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7311,536 0.6%   
Profit after tax Rs m12422,707 0.5%  
Gross profit margin %4.727.4 17.3%  
Effective tax rate %37.033.6 110.1%   
Net profit margin %3.016.6 18.0%  
BALANCE SHEET DATA
Current assets Rs m1,62997,790 1.7%   
Current liabilities Rs m1,05853,872 2.0%   
Net working cap to sales %13.732.1 42.8%  
Current ratio x1.51.8 84.8%  
Inventory Days Days3085 35.2%  
Debtors Days Days34121 27.7%  
Net fixed assets Rs m55686,379 0.6%   
Share capital Rs m78901 8.6%   
"Free" reserves Rs m878105,735 0.8%   
Net worth Rs m1,069109,844 1.0%   
Long term debt Rs m15953,739 0.3%   
Total assets Rs m2,399224,378 1.1%  
Interest coverage x7.677.9 9.7%   
Debt to equity ratio x0.10.5 30.3%  
Sales to assets ratio x1.70.6 284.0%   
Return on assets %6.410.3 62.1%  
Return on equity %11.620.7 56.1%  
Return on capital %18.521.2 87.0%  
Exports to sales %0.849.1 1.6%   
Imports to sales %1.47.4 18.8%   
Exports (fob) Rs m3367,244 0.0%   
Imports (cif) Rs m5810,199 0.6%   
Fx inflow Rs m3371,405 0.0%   
Fx outflow Rs m6317,807 0.4%   
Net fx Rs m-3053,598 -0.1%   
CASH FLOW
From Operations Rs m127-3,690 -3.4%  
From Investments Rs m-146-69,434 0.2%  
From Financial Activity Rs m2258,126 0.0%  
Net Cashflow Rs m3-14,998 -0.0%  

Share Holding

Indian Promoters % 65.4 46.6 140.3%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 3.7 11.3 32.7%  
FIIs % 5.2 31.9 16.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.1 255.4%  
Shareholders   12,723 98,259 12.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS